Goldman Sachs Group »

Rigel Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $21M 737k 28.33
2025-03-31 $1.1M 60k 17.99
2024-12-31 $2.8M 167k 16.82
2024-09-30 $746k 46k 16.18